ZURA: Zura Bio Limited O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
GURU.Markets agregat grafikdagi o'sish aksiyalari jozibadorligi ko'rsatkichi 0.00 darajasida qat'iy belgilangan. Zura Bio Limited (ZURA) kompaniyasining muvaffaqiyati klinik sinovlarning ijobiy natijalari va yetarli kapitalga bog'liq. Kompaniya biolaboratoriyalar bilan hamkorlik orqali o'z portfelini kengaytirmoqda va aktivlar sinergiyasini joriy etmoqda. Kelgusidagi daromadlar autoimmun patologiyalarni davolovchi sug'urta kompaniyalariga innovatsion antitelalarni yetkazib berishga asoslangan.
Zura Bio (ZURA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Zura Bio Limited|ZURA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Zura Bio Ltd|ZURA - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Zura Bio Limited|ZURA - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar Zura Bio|Tezkor likvidlik koeffitsiyenti zurabio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ZURA - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Zura Bio Limited|ZURA - P/E multiplikatori|Forvard P/E multiplikatori zurabio.com|ZURA - Narx-foyda va o‘sish multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Zura Bio Limited|ZURA - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Zura Bio|ZURA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi zurabio.com|ZURA - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Zura Bio Limited
Kompaniyaning umumiy tahlili:ZURA - zurabio.com
Faol tadqiqot va ishlanmalar (R&D) bosqichida innovatsion antitanalarni ishlab chiqayotgan Zura Bio Limited (ZURA) uchun joriy PEG koeffitsiyenti bozorning kelajakdagi foyda potentsialini baholash koeffitsiyenti sifatida xizmat qiladi. Ushbu ko'rsatkich P/E koeffitsiyentini foyda o'sish sur'atiga bo'lish orqali hisoblanadi; birdan past qiymat aktivning kengayishiga nisbatan past baholanganligini anglatadi, bu esa yuqori xavfli biotexnologiya kompaniyalarini tahlil qilishda muhim ahamiyatga ega.
Zura Bio Limited kimlar bilan raqobatlashadi
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH: Narx-foyda va o‘sish multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL (abcellera.com) - Narx-foyda va o‘sish multiplikatori|tourmalinebio.com (TRML) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|PHAR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori NKTR|PEG multiplikatori Upstream Pharma (UPB)|Zenas Biopharma Inc - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IMNM|Gossamer Bio - PEG multiplikatori|KALV: Narxning foydaga va o‘sish sur’atiga nisbati|SEPN: PEG multiplikatori|PVLA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Savara Inc.|O‘sish sur’atiga tuzatilgan narx-foyda rigel.com RIGL|Narx-foyda va o‘sish multiplikatori ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|rapt.com - Narxning foydaga va o‘sish sur’atiga nisbati|Aerovate - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati aclaristx.com ACRS|Kyverna Therapeutics, Inc. (KYTX) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori THTX (Theratechnologies Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati AVTX|PEG multiplikatori ELDN (Eledon Pharmaceuticals, Inc.)|Agenus, Inc. (AGEN) - O‘sish sur’atiga tuzatilgan narx-foyda|Climb Bio, Inc. - PEG multiplikatori|ATYR (aTyr Pharmaceuticals) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ADAG (adagene.com) - Narx-foyda va o‘sish multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati IMA (Ikena Oncology)|Narx-foyda va o‘sish multiplikatori STTK|PEG multiplikatori Equillium Bio|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|IMUX (immunic-therapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ATRA (Atara Bio)|PEG multiplikatori InflaRx NV IFRX|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ACET|CELU: PEG multiplikatori|INmune Bio Corporation - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|PEG multiplikatori kezarlifesciences.com|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Narx-foyda va o‘sish multiplikatori|GeoVax Labs, Inc. - PEG multiplikatori|EDSA - PEG multiplikatori|IBIO (iBio) - Narx-foyda va o‘sish multiplikatori|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|Bolt Bio (BOLT) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|Narx-foyda va o‘sish multiplikatori aptevotherapeutics.com APVO|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX - Narx-foyda va o‘sish multiplikatori|GRI: Narx-foyda va o‘sish multiplikatori|XRTX - PEG multiplikatori|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti REVB|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Scinai Immunotherapeutics Ltd SCNI|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|AFMD: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Allakos - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori HOOKIPA Pharma, Inc. HOOK|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ITOS (iTeos Therapeutics Inc)|OCEA: PEG multiplikatori|TC BioPharm Ltd (TCBP) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori THRD
